ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Quantum Genomics

Quantum Genomics (ALQGC)

0.0721
0.00
(0.00%)
Closed November 24 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0721
Bid
0.074
Ask
0.0721
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.1578
Market Cap
Previous Close
0.0721
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,688,577
Shares Outstanding
69,709,954
Dividend Yield
-
PE Ratio
-1.54
Earnings Per Share (EPS)
-0.05
Revenue
36k
Net Profit
-3.17M

About Quantum Genomics

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Quantum Genomics is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.001 € to 0.1578 €.

Quantum Genomics currently has 69,709,954 shares outstanding. The market capitalization of Quantum Genomics is 5.03 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -1.54.

ALQGC Latest News

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medications...

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around...

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12 million subscription commitments...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.07210.07210.072100DE
4000.07210.07210.072100DE
120.022846.2474645030.04930.1380.00116885770.05043206DE
26-0.0577-44.45300462250.12980.1380.0017849990.05191244DE
52-0.0281-28.04391217560.10020.15780.0014487370.05853711DE
156-4.2759-98.34176632934.3484.580.0013166460.51788887DE
260-2.9979-97.6514657983.076.1850.0013116291.81045019DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discussion

View Full Feed
knrorrel knrorrel 17 minutes ago
no chance in the quantum hype, $10 could come quickly now, like on Friday with qmco (+171%, only on Friday increased from $3.60 to $11!)

and it's a shame that they couldn't buy more,

but I feel the same way (I also have far too little of $QBTS but unfortunately I don'
QBTS
chen1992 chen1992 33 minutes ago
https://youtu.be/PaMsc8z1Ls4?si=u3MwvbGovNMyWXI6


Inverse Cramer at it again! Did it for TELL!!!!
TGLO
silkmaster silkmaster 35 minutes ago
It looks like we can only guss what would the pps will look like in a week/month or a year from now .
Mean while lets play what would the PPS look like come 30/11/24 so long as KT will come out and talk to the public by than that is ...

A. 0.09 (around current pps)
B. 0.
KBLB
ZLAZARUS ZLAZARUS 48 minutes ago
Ph3 melanoma data for IO102-IO103 remain on track for 1H25 and represents the next key catalyst. At .70 we are trading at cash. With a positive Ph3 melanoma readout we will be trading at $3.00 overnight with a march to $6.00 towards the later half of 2025. In addition, I'm encouraged by the support
IOBT
knrorrel knrorrel 52 minutes ago
https://de.tradingview.com/chart/Mq3nUQ7Y/?symbol=NYSE%3AQBTS
QBTS
knrorrel knrorrel 57 minutes ago
friday +171% / $11 and $Q_BTS follows on Monday, which is much better than QMCO and still has a lot of potential to trade above $10 ?
all only imho

here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175432596


QMCO
Whalatane Whalatane 1 hour ago
Yes There will be less of a reaction in the UNCY stock for the reason you mentioned
ARDX is saying they will supply Xphozah free of charge to Medicare patients who lose coverage in Jan ...for the first 2 mths only
Nephrologists are probably already pulling back from starting Medicare
ARDX UNCY
SCAMBUSTERKING SCAMBUSTERKING 1 hour ago
My statements are backed up by the court docs filed by Jake and his lawyer... then even more proven by the actions of Jake.
BCAP
Dodger1 Dodger1 1 hour ago
No Matter what. You all know you do family? Allegiances?

Alex Jones for Atty General...for sure.

Go $AABB
AABB
chereb19 chereb19 1 hour ago
An even bigger Whopper of a lie. Can't believe anything you write, there's are too many examples of your lies. Dishonest and incompetent?
RDGL
knrorrel knrorrel 1 hour ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
weedtrader420 weedtrader420 1 hour ago
☝️🤑☝️📈🚀
SUKUUSD
knrorrel knrorrel 1 hour ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
fuagf fuagf 2 hours ago
And all should understand subsidies discourage innovation leading to efficiency.
You're right too, we are talking about corporate farming in that respect also.
Ray_137 Ray_137 2 hours ago
That can be true plan 7 contains some parts of plan6. Investors in WAMU signed releases based on plan7.
COOP
Kam8 Kam8 2 hours ago
I am guessing $2+ after approval in UK, not only 27cents. 
NWBO
dstock07734 dstock07734 2 hours ago
George,

It could be none of them.
NWBO
snoopycomic snoopycomic 2 hours ago
Dufus- OS is the measurement.
NWBO
snoopycomic snoopycomic 2 hours ago
OS is the measurement fugue. Get with the program
NWBO
Dallas-Cowboys Dallas-Cowboys 2 hours ago
Natural gas and nuclear (a lot longer timeframe) are the answer to the massive Datacenters that are being constructed for AI. They already consume 100's of megawatts soon to be gigawatts of power. They use the equivalent consumption of neighborhoods and towns. Cranmer is a showman and sometimes Bozo
TGLO
236T568 236T568 2 hours ago
Good stuff

https://x.com/IanJaeger29/status/1860460658094903433?s=19

Your Recent History

Delayed Upgrade Clock